These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 232830)
21. Specific killing of RSV-transformed cells in vitro by lymphoid cells from RSV tumor-bearing chickens. Sasson ZB; Doljanski F; Weiss DW Isr J Med Sci; 1973 Mar; 9(3):258-65. PubMed ID: 4350973 [No Abstract] [Full Text] [Related]
22. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. Shu SY; Chou T; Rosenberg SA J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816 [TBL] [Abstract][Full Text] [Related]
23. Interaction of Chinese hamster embryonic cells with the helper-dependent Rous sarcoma virus. Hlozánek I; Lacinová J; Mach O Folia Biol (Praha); 1974; 20(5):291-9. PubMed ID: 4374399 [No Abstract] [Full Text] [Related]
24. Immune response to acute virus infection in the Syrian hamster. II. Studies on the identity of virus-induced cytotoxic effector cells. Nelles MJ; Duncan WR; Streilein JW J Immunol; 1981 Jan; 126(1):214-8. PubMed ID: 7005334 [TBL] [Abstract][Full Text] [Related]
25. Identification, functional characterization and partial purification of thymus-derived lymphocytes in inbred hamsters. Blasecki JW; Houston KJ Immunology; 1978 Jul; 35(1):1-11. PubMed ID: 308040 [TBL] [Abstract][Full Text] [Related]
26. Inhibition by lymphoid cellular factors of the immunological cytotoxicity against a syngeneic tumour. Lafontaine N; Firket H Pathol Eur; 1976; 11(2):147-50. PubMed ID: 958732 [TBL] [Abstract][Full Text] [Related]
27. Potential usefulness of a cultured glioma cell line induced by Rous sarcoma virus in B10.A mouse as an immunotherapy model. Sakamoto K; Hoshino H; Kiuchi Y; Nakano G; Nagamachi Y Jpn J Exp Med; 1989 Oct; 59(5):173-80. PubMed ID: 2559217 [TBL] [Abstract][Full Text] [Related]
28. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis. Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716 [TBL] [Abstract][Full Text] [Related]
29. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures. Hurrell SM; Zarling JM J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084 [TBL] [Abstract][Full Text] [Related]
31. Indomethacin inhibits kidney metastasis in bomirski melanoma-bearing hamsters, and modulates natural killer cytotoxic activity of tumor hosts in vivo and in vitro. Bigda J; Mysliwski A Anticancer Res; 1998; 18(5A):3549-54. PubMed ID: 9858938 [TBL] [Abstract][Full Text] [Related]
32. Comparison of N-acetylglucosaminyltransferase V activities in Rous sarcoma-transformed baby hamster kidney (RS-BHK) and BHK cells. Arango J; Pierce M J Cell Biochem; 1988 Jun; 37(2):225-31. PubMed ID: 2840447 [TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptors in Rous sarcoma virus-transformed cells of different hosts. Sovová V; Fidlerová H; Trnka D; Sloncová E Folia Biol (Praha); 1994; 40(5):291-9. PubMed ID: 7895858 [TBL] [Abstract][Full Text] [Related]
34. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors. Rosato A; Bronte V; Mandruzzato S; Zambon A; Calderazzo F; Biasi G; Zanovello P; Collavo D Int J Cancer Suppl; 1992; 7():24-7. PubMed ID: 1385341 [TBL] [Abstract][Full Text] [Related]
35. Nonspecific immunoprotection against Rous sarcoma tumor in chicks. Kishore S; Mallick BB Indian J Exp Biol; 1989 Jun; 27(6):525-8. PubMed ID: 2555299 [TBL] [Abstract][Full Text] [Related]
36. Cytotoxic activities of gut mucosal lymphoid cells in guinea pigs. Arnaud-Battandier F; Bundy BM; O'Neill M; Bienenstock J; Nelson DL J Immunol; 1978 Sep; 121(3):1059-65. PubMed ID: 690435 [TBL] [Abstract][Full Text] [Related]
37. Immune response against P815X2 mastocytoma growing in syngeneic DBA/2 mice. V. Spleen immunoreactivity and cell mediated cytotoxicity. Laatikainen A; Syrjänen K; Mäntyjärvi R; Tosi P Arch Geschwulstforsch; 1987; 57(4):265-74. PubMed ID: 3118852 [TBL] [Abstract][Full Text] [Related]
38. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. Yoshizawa H; Chang AE; Shu S J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072 [TBL] [Abstract][Full Text] [Related]
39. Functional analysis of mononuclear cells infiltrating into tumors. II. Differential ability of mononuclear cells obtained from various tissues to produce helper factors that are involved in the generation of cytotoxic cells. Uede T; Kohda H; Ibayashi Y; Osawa H; Diamantstein T; Kikuchi K J Immunol; 1985 Nov; 135(5):3243-51. PubMed ID: 3900205 [TBL] [Abstract][Full Text] [Related]
40. Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites. Ksander BR; Streilein JW J Immunol; 1989 Jul; 143(2):426-31. PubMed ID: 2500481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]